Other languages TheraVet SA

Equities

ALVET

BE0974387194

Market Closed - Euronext Paris Other stock markets 11:35:13 2024-05-31 am EDT			5-day change	1st Jan Change
0.598 ^EUR	+0.34%		-6.27%	-58.76%

May. 21	TheraVet SA Announces Early Completion of Patient Recruitment of the Visco-VET Clinical Study	CI
May. 07	FOMO is Back

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TheraVet Announces Early Completion of Patient Recruitment of the VISCO-VET Clinical Study	May. 21
TheraVet SA Announces Early Completion of Patient Recruitment of the Visco-VET Clinical Study	May. 21
FOMO is Back	May. 07
TheraVet Unveils Its Development Strategy to Address the Equine Market	May. 07
TheraVet reports Full-Year 2023 Financial Results and Provides the Preparatory Documents for the General Meeting of June 6th, 2024	Apr. 23
TheraVet SA Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 23
TheraVet Reports 2023 Full Year and 2024 First Quarter Revenues	Apr. 10
BIOCERA-VET® Is Now Available for the Management of Dental and Orthopedics Conditions in Horses	Mar. 13
TheraVet SA Announces the Launch of BIOCERA-VET Equine	Mar. 13
TheraVet’s Veterinary Medicinal Product Gets Patents in Europe, Singapore, Israel	Jan. 30
Global markets live: Charles Schwab, Apple, Spirit Airlines, BP, Visa...	Jan. 17
TheraVet SA Announces Commercial Launch of Biocera-VET in Germany	Jan. 17
Global markets live: Boeing, GSK, Hays, Shell, Eli Lilly...	Jan. 09
TheraVet Announces Agreement with Alcyon Italia for the Distribution of BIOCERA-VET® Product Line in Italy	Jan. 09
TheraVet : retours positifs dans l'ostéosarcome canin	Jan. 04
TheraVet : lancement d'une étude dans l'ostéosarcome	Nov. 23
TheraVet SA Announces Launch of Biocera-Vet Canine Osteosarcoma Study Conducted by the University of Florida	Nov. 23
TheraVet Sets Up EUR3 Million Equity-linked Funding Facility	Nov. 21
TheraVet SA announced that it expects to receive ?1 million in funding	Nov. 19
Vet Biotech TheraVet Names CFO	23-10-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages TheraVet SA

Equities

ALVET

BE0974387194

Other languages

Filters